Cargando…
Nigella sativa L as a potential phytotherapy for coronavirus disease 2019: A mini review of in silico studies
BACKGROUND: Coronaviruses are responsible for several human diseases, such as the infectious novel coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Nigella sativa is a natural food supplement with a known safety profile that may pr...
Autores principales: | Koshak, Dr Abdulrahman E., Koshak, Prof Emad A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445151/ https://www.ncbi.nlm.nih.gov/pubmed/32863400 http://dx.doi.org/10.1016/j.curtheres.2020.100602 |
Ejemplares similares
-
Medicinal benefits of Nigella sativa in bronchial asthma: A literature review
por: Koshak, Abdulrahman, et al.
Publicado: (2017) -
Comparative Immunomodulatory Activity of Nigella sativa L. Preparations on Proinflammatory Mediators: A Focus on Asthma
por: Koshak, Abdulrahman E., et al.
Publicado: (2018) -
Nigella sativa for the treatment of COVID-19: An open-label randomized controlled clinical trial
por: Koshak, Abdulrahman E., et al.
Publicado: (2021) -
Nigella Sativa Supplementation Accelerates Recovery from Mild COVID-19: First Randomized Controlled Trial
por: Koshak, Abdulrahman, et al.
Publicado: (2021) -
Nigella sativa supplementation to treat symptomatic mild COVID-19: A structured summary of a protocol for a randomised, controlled, clinical trial
por: Koshak, Abdulrahman E., et al.
Publicado: (2020)